Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
Vincent C. Marconi, A. Ramanan, S. de Bono, Cynthia E. Kartman +99 more

